Sign in

You're signed outSign in or to get full access.

Giovanna Kampouri Monnas

Director at APTARGROUPAPTARGROUP
Board

About Giovanna Kampouri Monnas

Independent director of AptarGroup, Inc. since 2010; age 69; Chair of the Management Development & Compensation Committee. Former senior executive at Procter & Gamble and Joh A. Benckiser (final role: President of Benckiser International), with deep experience across global consumer, fragrance, and cosmetics markets; nominated for a term expiring in 2028 based on senior leadership credentials and market expertise .

Past Roles

OrganizationRoleTenureCommittees/Impact
Puig S.L.Director2006–2022Board service at global fragrance/skin care leader
Exea VenturesChair2018–2021Led global family investment firm board
Randstad Holding NVSupervisory Board Member2006–2018Chair of Compensation Committee
Imerys S.A.Director2015–2018Board service at industrial minerals company
GrowthFund (Greek national fund)DirectorNot statedBoard service (prior)
TNT (Dutch logistics)DirectorNot statedBoard service (prior)
Joh A. Benckiser GmbHPresident, Benckiser International; Management Board memberNot statedSenior leadership in consumer goods
Procter & GambleExecutive rolesNot statedGlobal consumer goods experience

External Roles

CategoryCurrent Roles
Public company boardsNone (proxy “Other Public Company Boards”: “-”)
Non-profit/academicNot disclosed in ATR proxy for current service (prior roles noted above)

Board Governance

  • Committee assignments: Chair, Management Development & Compensation (MDC); not on Audit or Corporate Governance committees .
  • Committee composition and meetings 2024: MDC (6 meetings), Audit (8), Corporate Governance (4); all three committees are 100% independent and governed by Board-approved charters .
  • Compensation Committee membership: Giovanna Kampouri Monnas (Chair), Craig Owens, Ralf K. Wunderlich, Julie Xing; committee recommended inclusion of CD&A and oversees executive pay program .
  • Independence: Board is 90% independent; Monnas is affirmatively determined independent under NYSE standards .
  • Attendance: Board met 7 times in 2024; no current director attended fewer than 75% of aggregate Board and committee meetings; Aptar has no formal annual meeting attendance policy (named attendees listed) .
  • Governance practices: Separate independent Chair & CEO; majority voting for directors with resignation policy; independent directors meet regularly in executive session; prohibition on hedging/pledging; director stock ownership requirements .

Committee Role Summary (2024)

CommitteeRoleMeetings in 2024
Management Development & CompensationChair6
Audit8 (context)
Corporate Governance4 (context)

Fixed Compensation

Component (2024)Amount (USD)Notes
Annual cash retainer$100,000Standard non-employee director retainer
MDC Committee Chair retainer$22,000Chair fee for Management Development & Compensation Committee
Total cash fees (reported)$122,000Fees earned or paid in cash for Monnas in 2024
Other compensation$2,000Company matching gift (charitable)
  • Program context: Director cash/equity levels positioned near market median; 2024 changes vs 2023 included a $10,000 increase in annual equity grant per non-employee director and $7,500 increase to Chair’s cash retainer (program-level) .

Performance Compensation

Equity Element (2024)DetailAmount/Units
Annual RSU grant (non-employee directors)Granted May 1, 20241,113 RSUs to each non-employee director (Chair: 1,304)
Grant date fair value per shareDiscounted for dividends not received during vesting$143.82 per share (2024 director grants)
Reported stock award value (Monnas)Grant date fair value$160,072
Vesting/settlementRSU restriction periods set by the Compensation Committee; dividend equivalents subject to same vesting conditions; RSUs cannot be transferred during restriction period
Near-term vesting indicatorRSUs vesting within 60 days of Mar 14, 2025 (Monnas)1,113 RSUs
Director award limitAggregate annual cash + equity cap$500,000 per fiscal year for a non-employee director

Notes:

  • Director RSUs are time-based awards under the 2018 Plan; performance-conditioned PRSUs apply to executives, not to directors. Dividend equivalents on RSUs are subject to vesting; repricing of options/SARs is prohibited; minimum one-year vesting applies to at least 95% of shares under the plan, subject to change-in-control/termination accelerations per committee discretion .

Other Directorships & Interlocks

Company/OrganizationSectorRolePotential Interlock/Exposure
Puig S.L. (prior)Fragrance/BeautyDirectorIndustry adjacency to Aptar’s beauty/pharma packaging customers; no related party transactions disclosed
Randstad Holding NV (prior)HR ServicesSupervisory Board; Chair Comp CommitteeGovernance and human capital expertise; no RPTs disclosed
Imerys S.A. (prior)Industrial MineralsDirectorMaterials industry experience; no RPTs disclosed
Exea Ventures (prior)Family investmentChairPrivate investment experience; no RPTs disclosed
GrowthFund (prior)Sovereign fundDirectorPolicy/finance exposure; no RPTs disclosed
TNT (prior)LogisticsDirectorSupply chain exposure; no RPTs disclosed
  • Related party transactions: Audit Committee approves all related person transactions; none requiring disclosure since Jan 1, 2024 .
  • Policy: Directors prohibited from hedging or pledging Aptar stock; insider trading policy enforced .

Expertise & Qualifications

  • Senior leadership in global consumer goods (P&G; Benckiser International President) and deep sector expertise in fragrance/cosmetics; global marketing credentials cited by Board as qualifications for continued service .

Equity Ownership

HolderShares OwnedRSUs Vesting within 60 Days of Mar 14, 2025Ownership %
Giovanna Kampouri Monnas7,5821,113Less than 1% (*)
  • Director stock ownership guidelines: Non-executive directors must hold Aptar shares valued at ≥5× annual cash retainer ($500,000); compliance required within five years; as of record date, each non-employee director is compliant or within phase-in .
  • Hedging/pledging prohibited for directors and executive officers .

Governance Assessment

  • Board effectiveness: Monnas chairs a fully independent MDC Committee with documented best practices, including use of an independent consultant (Pay Governance) and a robust 2018 Plan framework prohibiting repricing and current-payment of dividends on unearned awards; minimum vesting periods strengthen alignment .
  • Alignment and incentives: Director pay mix balances cash ($122k) and equity (~$160k RSUs) with clear ownership guidelines (5× retainer) and hedging/pledging prohibitions—supporting long-term alignment; her RSUs scheduled to vest within 60 days of March 14, 2025 indicate ongoing equity-based exposure .
  • Independence and engagement: Affirmatively independent under NYSE standards; Board and committee meeting cadence (7 Board; MDC 6) with no director below 75% attendance threshold signals engagement; separate independent Chair & CEO and regular executive sessions enhance oversight .
  • Conflicts/related-party risk: No related person transactions disclosed for directors since Jan 1, 2024; Audit Committee oversight of RPTs and cybersecurity adds discipline; no Section 16(a) filing issues noted for Monnas (one late Form 4 in 2024 pertained to a different executive) .
  • Signal watch: Program-level increases to director equity grants in 2024 (+$10k) suggest board’s desire to reinforce equity alignment without introducing performance-conditioned director pay (common market practice); non-employee director compensation capped at $500k under plan .

RED FLAGS: None identified in proxy disclosures for Monnas (no RPTs; prohibited hedging/pledging; independent status; attendance threshold met) .